Clinical Trial Update: Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating stage-based, risk-adapted therapy for children with neuroblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Neuroblastoma | Phase 3 | Status: COMPLETED